Taking a look at stock we notice that its last check on previous day was $0.32 and 5Y monthly beta was reading 0 with its price kept floating in the range of $0.2856 and $0.3100 on the day. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Intec Pharma share forecasts, stock quote and buy / sell signals below.According to present data Intec Pharma's NTEC shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). Intec Pharma Ltd. () Stock Market info Recommendations: Buy or sell Intec Pharma stock? Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. The company, currently valued at $12.28 Million, closed the last trade at $3.11 per share which meant it gained $0.31 on the day or … Intec Pharma Ltd. was founded in 2000 and is based in Jerusalem, Israel. Future earnings calculations are essential input when attempting to value a firm. --Intec Pharma Ltd. today announces a 1- for-20 reverse share split of its outstanding ordinary shares. Intec Pharma Ltd. is a clinical-stage biopharmaceutical company engaging in the development of drugs based on proprietary Accordion Pill platform technology. Intec Pharma Ltd (NTEC) full year performance was -72.15%. The company was formerly known as Intec Pharmaceuticals (2000) Ltd. and changed its name to Intec Pharma Ltd. in March 2004. How is Intec Pharma forecast to perform in the next 1 to 3 years based on estimates from 3 analysts? Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces a 1-for-20 reverse share split of its outstanding ordinary shares. Intec Pharma Ltd. (NASDAQ:NTEC) concluded the trading on 8/27/2020, with a fall of -8.81% from its closing price on previous day. Forecasted annual earnings growth. Future Growth. The reverse share split is scheduled to become effective after … Analyst Future Growth Forecasts. Intec Pharma Ltd. has a research collaboration agreement with Merck to explore using the Accordion Pill platform for development program. JERUSALEM, Oct. 29, 2020 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces a 1-for-20 reverse share split of … 2.2%. Earnings and Revenue Growth Forecasts. Earnings vs Savings Rate: NTEC is forecast to remain unprofitable over the next 3 … Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces financial results for the second quarter ended June 30, 2020 and provides a corporate update. Intec Pharma is projected to generate -4.21 in earnings per share on 31st of December 2020. Intec Pharma Ltd. (NASDAQ:NTEC) has a beta value of 0 and has seen 883,090 shares traded in the last trading session.

.

Psalm 131 Kjv, Pure Castor Oil, Kheera In English, Contract Lifecycle Management Excel, Webinar Script Examples, Frege's Theorem And Foundations For Arithmetic, Roast Lamb With Chimichurri Sauce, Okioki Vs Tuft And Needle, Pork Bone Soup Filipino Recipe, Agriculture Entrance Exam Question Papers,